Enovis Corporation

Enovis Corporation is a global medical technology company dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. The company's mission is to fuel active lifestyles through innovation in orthopedics and beyond. Headquartered in Wilmington, Delaware, U.S., Enovis operates with a focus on continuous improvement, guided by its Enovis Growth Excellence (EGX) business system.

Enovis operates through two primary segments: Prevention & Recovery (P&R) and Reconstructive. The P&R segment offers a wide range of orthopedic braces, supports, cold therapy systems, and rehabilitation products under well-known brands such as DonJoy, Aircast, Exos, ProCare, Compex, Chattanooga, and Dr. Comfort. The Reconstructive segment provides surgical implants and instruments for joint replacement and repair across the hip, knee, shoulder, elbow, foot, and ankle. This segment incorporates advanced technologies like the ARVIS® Augmented Reality System for surgical guidance and the DynaNail® Helix for foot and ankle fixation. Additionally, the company offers the MotionMD™ workflow automation platform to enhance operational efficiencies for healthcare providers.

Formerly known as Colfax Corporation, the company rebranded to Enovis in April 2022 following the spin-off of its industrial business. Damien McDonald was appointed Chief Executive Officer in May 2025, succeeding Matt Trerotola. Enovis completed the acquisition of LimaCorporate S.p.A. in January 2024, further expanding its reconstructive offerings. The company reported solid organic growth in its fourth quarter and full-year 2025 results, projecting full-year 2025 revenue between $2.24 billion and $2.27 billion. Enovis is positioned as an innovation-driven medical technology growth company, strategically targeting market share gains in the fast-growing Ambulatory Surgery Center (ASC) market despite intense competition from larger players.